Work with the Systems Engineering team to diagnose and resolve complex mechanical, software, and system integration issues to minimize equipment downtime and maintain operational continuity
Collaborate with folks from our machine learning, software engineering and scientific groups to solve questions ranging from technology onboarding, minimizing batch effects, or process improvements
Identify opportunities in how we develop, test and deploy automation solutions more efficiently
Work with automation leadership to create a census of automation, its current usage, and develop and implement a plan for areas of retirement, growth, or re-deployment.
ABOUT YOU
Bachelor's degree or higher in Robotics, Mechanical, Electrical, Chemical, Software or Bioengineering, or Physics, Chemistry or Biology
B.S, with 8+ years, M.S with 6+ years, or Ph.D. with 3+ years of professional experience working with automation hardware
Proficiency in automation and systems development/integration within the life sciences industry, specifically with robotics and liquid handling platforms
Proficiency in software programming (Python, SQL, and/or C#) and data handling (including database work) is highly preferred
You understand existing capabilities of the lab automation industry and have a track record showing technical depth in automation systems of varying scale
You are comfortable completing work independently on complex projects and can also give guidance to others on daily work
You have experience in managing the relationship to other engineering functions (eg. third party service providers and vendors or internal mechanical or software engineering teams)
You have experience automating scientific workflows (ex. Cell Culture, Genomic Screening or DNA-encoded Library processes)
COMPENSATION & BENEFITS AT INSITRO
Our target starting salary for successful US-based applicants for this role is $147,000 - $183,000. To determine starting pay, we consider multiple job-related factors including a candidate's skills, education and experience, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data.
This role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and our Equity Incentive Plan, subject to the terms of those plans and associated policies.
In addition, insitro also provides our employees
401(k) plan with employer matching for contributions
Excellent medical, dental, and vision coverage as well as mental health and well-being support
Open, flexible vacation policy
Paid parental leave of at least 16 weeks to support parents who give birth, and 10 weeks for a new parent (inclusive of birth, adoption, fostering, etc)
Quarterly budget for books and online courses for self-development
New hire stipend for home office setup
Monthly cell phone & internet stipend
Access to free onsite baristas and daily lunch for employees who are either onsite or hybrid
Access to a free commuter bus network that provides transport to and from our South San Francisco HQ from locations all around the Bay Area
insitro is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.
We believe diversity, equity, and inclusion need to be at the foundation of our culture. We work hard to bring together diverse teams–grounded in a wide range of expertise and life experiences–and work even harder to ensure those teams thrive in inclusive, growth-oriented environments supported by equitable company and team practices. All candidates can expect equitable treatment, respect, and fairness throughout the interview process.
#LI-Onsite
Please be aware of recruitment scams: we never request payments, all recruitment communications are from @insitro.com http://insitro.com, and if in doubt, contact us at info@insitro.com.
About insitro
insitro is a drug discovery and development company using machine learning (ML) and data at scale to decode biology for transformative medicines. At the core of insitro’s approach is the convergence of in-house generated multi-modal cellular data and high-content phenotypic human cohort data. We rely on these data to develop ML-driven, predictive disease models that uncover underlying biologic state and elucidate critical drivers of disease. These powerful models rely on extensive biological and computational infrastructure and allow insitro to advance novel targets and patient biomarkers, design therapeutics and inform clinical strategy. insitro is advancing a wholly owned and partnered pipeline of insights and therapeutics in neuroscience and metabolism. Since launching in 2018, insitro has raised over $700 million from top tech, biotech and crossover investors, and from collaborations with pharmaceutical partners. For more information on insitro, please visit www.insitro.com http://www.insitro.com.
